Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population

Neuroscience Letters

Volumn 363, Issue 2, 2004, Pages 131-133

  Rosenmann, Hanna ^a   Meiner, Zeev ^a   Dresner Pollak, Rivka ^a   Kahana, Esther ^b   Aladjem, Zoja ^b   Grenader, Tal ^a   Wertman, Eli ^c   Abramsky, Oded ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

^c HERZOG HOSPITAL   (Israel)

Author keywords

Alzheimer's disease; Association study; Inflammation; Interleukin 1beta; Polymorphism

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; EXON; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; ENCEPHALITIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INTERLEUKIN-1; JEWS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 2542477002     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.03.063     Document Type: Article

References (21)

1. Bertram L., Blacker D., Crystal A., Mullin K., Keeney D., Jones J., Basu S., Yhu S., Guenette S., McInnis M., Go R., Tanzi R. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp. Gerontol. 35:2000;1353-1361
2. Cacabelos R., Barquero M., Garcia P., Alvarez X.A., Varela de Seijas E. Cerebrospinal fluid interleukin-1beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 13:1991;455-458
3. Cockrell J.R., Folstein M.F. Mini-Mental State Examination (MMSE). Psychopharmacol. Bull. 24:1988;689-692
4. Gibertini M. Cytokines and cognitive behavior. Neuroimmunomodulation. 5:1998;160-165
5. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615
6. Grimaldi L.M., Casadei V.M., Ferri C., Veglia F., Licastro F., Annoni G., Biunno I., De Bellis G., Sorbi S., Mariani C., Canal N., Griffin W.S., Franceschi M. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann. Neurol. 47:2000;361-365
7. Hedley R., Hallmayer J., Groth D.M., Brooks W.S., Gandy S.E., Martins R.N. Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann. Neurol. 51:2002;795-797
8. Li Y., Liu L., Kang J., Sheng J.G., Barger S.W., Mrak R.E., Griffin W.S. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20:2000;149-155
9. Ma S.L., Tang N.L., Lam L.C., Chiu H.F. Lack of association of the interleukin-1beta gene polymorphism with Alzheimer's disease in a Chinese population. Dement. Geriatr. Cogn. Disord. 16:2003;265-268
10. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33:(5):1998;371-378
11. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944
12. Nicoll J.A., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., Esiri M.M., Murray L.S., Dewar D., Love S., Moss T., Griffin W.S. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 47:2000;365-368
13. Pericak-Vance M.A., Haines J.L. Genetic susceptibility to Alzheimer disease. Trends Genet. 11:(12):1995;504-508
14. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J. TaqI polymorphism in the human interleukin-1beta (IL-1beta) gene correlates with IL-1beta secretion in vitro. Eur. J. Clin. Invest. 22:1992;396-402
15. Rachal-Pugh C., Fleshner M., Watkins L.R., Maier S.F., Rudy J.W. The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci. Biobehav. Rev. 25:2001;29-41
16. Sciacca F.L., Ferri C., Licastro F., Veglia F., Biunno I., Gavazzi A., Calabrese E., Martinelli Boneschi F., Sorbi S., Mariani C., Franceschi M., Grimaldi L.M. Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol. Aging. 24:2003;927-931
17. Sheng J.G., Griffin W.S., Royston M.C., Mrak R.E. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 24:1998;278-283
18. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin W.S. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766
19. Sheng J.G., Mrak R.E., Griffin W.S. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56:1997;285-290
20. Sheng J.G., Mrak R.E., Griffin W.S. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 21:1995;290-301
21. Wang X., DeKosky S.T., Luedecking-Zimmer E., Ganguli M., Kamboh I.M. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. Hum. Genet. 110:2002;356-365